COne hundred million supplemental doses of future covid-19 vaccines were reserved for the poorest countriesannounced on Tuesday the global alliance for vaccination, the Gavi, which works in conjunction with the World Health Organization (WHO).
In early August, Gavi and the Bill and Melinda Gates Foundation had already announced an agreement with the Serum Institute of India (SII), the world’s largest vaccine manufacturer, to guarantee the supply of 100 million doses to these less favored countries .
The vaccines will be sold for $ 3 per dose, according to this international alliance, with the possibility of obtaining more.
Developed by the Swedish-British pharmaceutical companies AstraZeneca and the American Novavax, the vaccines will be manufactured by the SII that will donate them to the coalition against the coronavirus created by the WHO and called Covax (Covid-19 Vaccine Global Access, global access to vaccine against covid -19).
This collaboration will allow the Indian institute to increase its production capacity from the beginningOnce one or more vaccines have obtained regulatory approval and authorization from the WHO, doses may be distributed in low- and middle-income countries, although not until the first half of 2021.
Within the framework of this collaboration, AstraZeneca’s potential vaccine will be available to 61 countries, while Novavax’s will be available to the 92 countries supported by the Covax mechanism.
“No country, rich or poor, should be left behind when it comes to covid-19 vaccines,” said Dr. Seth Berkley, Gavi’s CEO, in a statement.
The Covax mechanism is part of the international device created by the UN to accelerate equitable access to tools to fight covid-19, the ACT Accelerator.
The WHO has set a goal of having 2 billion doses of vaccines available by the end of 2021.
Gallery: These are the countries that have already set aside vaccines against Covid-19 (Fifth Power)